Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 46, Issue , 2013, Pages 29-35

  Poleszak, Ewa ^a   Wośko, Sylwia ^a   Serefko, Anna ^a   Szopa, Aleksandra ^a   Wlaź, Aleksandra ^a   Szewczyk, Bernadeta ^b   Nowak, Gabriel ^b,c   Wlaź, Piotr ^d  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Antidepressant like activity; Forced swim test; Ifenprodil; Mice; NMDA receptor ligands

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; CYCLOSERINE; DEXTRO SERINE; DIZOCILPINE; IFENPRODIL; MAGNESIUM DERIVATIVE; MAGNESIUM HYDROASPARTATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; ZINC DERIVATIVE; ZINC HYDROASPARTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; DEPRESSION; DRUG ANTAGONISM; DRUG POTENTIATION; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN;

7-CHLORO-4-HYDROXY-3-(3-PHENOXY)PHENYLQUINOLIN-2[1H]-ONE; ANTIDEPRESSANT-LIKE ACTIVITY; CGP 37849; D-CYCLOSERINE (D-4-AMINO-3-ISOXAZOLIDONE); D-SERINE; DCS; DIZOCILPINE ((5R,10S)-(+)-5-METHYL-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5,10-IMINE HYDROGEN MALEATE); DL-/E/-AMINO-4-METHYL-5-PHOSPHONO-3-PENTENOIC ACID; DS; FORCED SWIM TEST; FST; I.C.V; I.P; IFENPRODIL; INTRACEREBROVENTRICULARLY; INTRAPERITONEALLY; L-701,324; MICE; MK-801; N-METHYL-D-ASPARTATE; NMDA; NMDA RECEPTOR LIGANDS; TAIL SUSPENSION TEST; TST;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; MALE; MICE; MOTOR ACTIVITY; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; SWIMMING; TREATMENT OUTCOME;

EID: 84880361652     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.06.001     Document Type: Article

References (55)

1. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47:351-354.
2. Bhatt J.M., Prakash A., Suryavanshi P.S., Dravid S.M. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating. Mol Pharmacol 2013, 83:9-21.
3. Contreras P.C., Bremer M.E., Gray N.M. Ifenprodil and SL 82.0715 potently inhibit binding of [3H](+)-3-PPP to sigma binding sites in rat brain. Neurosci Lett 1990, 116:190-193.
4. Coughenour L.L., Barr B.M. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits. J Pharmacol Exp Ther 2001, 296:150-159.
5. Decollogne S., Tomas A., Lecerf C., Adamowicz E., Seman M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol Biochem Behav 1997, 58:261-268.
6. Dhir A., Kulkarni S.K. Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test. Indian J Exp Biol 2008, 46:164-170.
7. Eby G.A., Eby K.L. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006, 67:362-370.
8. Eby G.A., Eby K.L., Murck H. Magnesium and major depression. Magnesium in the central nervous system 2011, 313-330. University of Adelaide Press, Adelaide. R. Vink, M. Nechifor (Eds.).
9. Farlow M.R. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Geriatrics 2004, 59:22-27.
10. Ghasemi M., Montaser-Kouhsari L., Shafaroodi H., Nezami B.G., Ebrahimi F., Dehpour A.R. NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Psychopharmacology (Berl) 2009, 206:325-333.
11. Giménez-Llort L., Ferré S., De Vera N., Martínez E. Motor depressant effects of systemically administered polyamines in mice: involvement of central NMDA receptors. Eur J Pharmacol 1996, 318:231-238.
12. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009, 61:105-123.
13. Hashimoto K., London E.D. Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. Eur J Pharmacol 1993, 236:159-163.
14. Hashimoto K., London E.D. Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors. Eur J Pharmacol 1995, 273:307-310.
15. Kew J.N., Trube G., Kemp J.A. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 1996, 497:761-772.
16. Law A.J., Deakin J.F. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 2001, 12:2971-2974.
17. Lipman J.J., Spencer P.S. Rapid intracerebroventricular injection assisted by an automatic syringe. J Pharmacol Methods 1980, 4:327-333.
18. Lopes T., Neubauer P., Boje K.M. Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test. Pharmacol Biochem Behav 1997, 58:1059-1064.
19. Maes M., Vandoolaeghe E., Neels H., Demedts P., Wauters A., Meltzer H.Y., et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 1997, 42:349-358.
20. Maj J., Rogóz Z., Skuza G. The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Pol J Pharmacol Pharm 1992, 44:217-226.
21. Maj J., Rogóz Z., Skuza G., Sowińska H. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol 1992, 2:37-41.
22. Maj J., Rogóz Z., Skuza G., Sowińska H. The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm 1992, 44:337-346.
23. Monaghan D.T., Jane D.E. Pharmacology of NMDA receptors. Frontiers in Neuroscience 2009, CRC Press, North Carolina, Boca Raton (FL). A.M. Van Dongen (Ed.).
24. Mony L., Zhu S., Carvalho S., Paoletti P. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. EMBO J 2011, 30:3134-3146.
25. Nowak G., Siwek M., Dudek D., Zieba A., Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 2003, 55:1143-1147.
26. Nowak G., Szewczyk B., Pilc A. Zinc and depression. An update. Pharmacol Rep 2005, 57:713-718.
27. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177:245-255.
28. Poleszak E. Modulation of antidepressant-like activity of magnesium by serotonergic system. J Neural Transm 2007, 114:1129-1134.
29. Poleszak E., Wlaź P., Szewczyk B., Kedzierska E., Wyska E., Librowski T., et al. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: behavioral and pharmacokinetic studies in mice. Pharmacol Biochem Behav 2005, 81:524-529.
30. Poleszak E., Wlaź P., Kedzierska E., Nieoczym D., Wróbel A., Fidecka S., et al. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 2007, 88:158-164.
31. Poleszak E., Wlaź P., Wróbel A., Dybała M., Sowa M., Fidecka S., et al. Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep 2007, 59:595-600.
32. Poleszak E., Szewczyk B., Wlaź A., Fidecka S., Wlaź P., Pilc A., et al. D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol Rep 2008, 60:996-1000.
33. Poleszak E., Wlaź P., Szewczyk B., Wlaź A., Kasperek R., Wróbel A., et al. A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice. J Neural Transm 2011, 118:1535-1546.
34. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
35. Preskorn S.H., Baker B., Kolluri S., Menniti F.S., Krams M., Landen J.W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 2008, 28:631-637.
36. Pruus K., Rudissaar R., Allikmets L., Harro J. The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats. Methods Find Exp Clin Pharmacol 2010, 32:123-128.
37. Rogóz Z., Skuza G., Maj J., Danysz W. Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 2002, 42:1024-1030.
38. Rogóz Z., Skuza G., Kuśmider M., Wójcikowski J., Kot M., Daniel W.A. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies. Pol J Pharmacol 2004, 56:179-185.
39. Rosa A.O., Lin J., Calixto J.B., Santos A.R., Rodrigues A.L. Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 2003, 144:87-93.
40. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004, 61:705-713.
41. Siwek M., Dudek D., Paul I.A., Sowa-Kućma M., Zieba A., Popik P., et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 2009, 118:187-195.
42. Siwek M., Dudek D., Schlegel-Zawadzka M., Morawska A., Piekoszewski W., Opoka W., et al. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord 2010, 126:447-452.
43. Szewczyk B., Brański P., Wierońska J.M., Palucha A., Pilc A., Nowak G. Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol 2002, 54:681-685.
44. Szewczyk B., Poleszak E., Wlaź P., Wróbel A., Blicharska E., Cichy A., et al. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:323-329.
45. Szewczyk B., Poleszak E., Sowa-Kućma M., Wróbel A., Słotwiński S., Listos J., et al. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids 2010, 39:205-217.
46. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010, 62:405-496.
47. Tricklebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 1989, 167:127-135.
48. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990, 185:1-10.
49. Wedzony K., Klimek V., Nowak G. Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849-a competitive antagonist of NMDA receptors. Pol J Pharmacol 1995, 47:537-540.
50. Willetts J., Balster R.L., Leander J.D. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 1990, 11:423-428.
51. Williams K. Extracellular modulation of NMDA receptors. Biology of the NMDA receptor 2009, CRC Press. A.M. Van Dongen (Ed.).
52. Willner P., Scheel-Kruger J., Belzung C. The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 2012, 10.1016/j.neubiorev.2012.12.007.
53. Wlaź P., Kasperek R., Wlaź A., Szumiło M., Wróbel A., Nowak G., et al. NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacol Rep 2011, 63:1526-1532.
54. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006, 63:856-864.
55. Zarate C.A., Singh J.B., Quiroz J.A., De J.G., Denicoff K.K., Luckenbaugh D.A., et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry 2006, 163:153-155.